We previously showed that rhPRG4 treatment reduces IL-1β and NF-κB p65 nuclear contents through a PRG4-CD44-dependent mechanism in OA and RA synoviocytes [40,107]. This evidence concerns the gene PRG4 and rheumatoid arthritis.